A comparative study of idarubicin 12 mg/m(2) and 8 mg/m(2) combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients

OBJECTIVE: This study aimed to explore a suitable dose of idarubicin (IDA) combined with cytarabine for the initial induction regimen for acute myeloid leukemia (AML) patients. PATIENTS AND METHODS: A total of 100 adult patients with de novo AML aged between 14 years and 80 years were enrolled in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Li, Liu, Xin, Liu, Huilan, Zhu, Weibo, Cai, Xiaoyan, Song, Kaidi, Zheng, Changcheng, Tang, Baolin, Sun, Zimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778788/
https://www.ncbi.nlm.nih.gov/pubmed/27013891
http://dx.doi.org/10.2147/OTT.S96176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778788/
https://www.ncbi.nlm.nih.gov/pubmed/27013891
http://dx.doi.org/10.2147/OTT.S96176

Ejemplares similares